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特 集：新しい時代の医療を拓く－診断と治療法の最前線－
凍結療法の現状と展望


























































































図４ 腎動脈塞栓術後単純 CT 斜冠状断像
腫瘍部分のみにリピオドールが集積し，高吸収になっている。
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Current status and prospect of cryotherapy
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SUMMARY
Cryotherapy is the latest minimally invasive treatment classified as non-vascular interventional
radiology（IVR）. Fine needles are used for percutaneous puncture of tumors under imaging
guidance. Using high-pressure argon gas for freezing, the needle tip is brought to an extremely low
temperature（-４０℃）or lower, and the tumor cells are frozen and destroyed. The advantages of
this treatment are that the freezing range can be confirmed on imaging during the procedure, and pain
is less intense during the treatment. Currently, in Japan, cryotherapy for tumors, such as renal
cancer, is being performed in fewer than３０hospitals.
Our hospital decided to introduce a cryotherapy device in ２０１６, and preparations for the
operation started at the end of ２０１６. In ２０１７, three in-hospital briefings were held, and we also
conducted a tour of facilities with installed cryotherapy devices. After this preparation period, the
first treatment was performed at the Tokushima Prefecture in March ２０１８. By August ２０１９,
cryotherapy had been performed in seven cases of renal cell carcinoma. In all cases, the treatment
was completed without serious complications and could be performed during the scheduled hospital
stay. At the follow-ups, no residual or recurrent tumors were found after only one treatment.
Currently, only small-diameter renal malignancies are covered by insurance. Therefore, the
Japanese Society of Interventional Radiology has submitted a request for the expansion of
indications for cryotherapy to the Ministry of Health, Labor and Welfare. In the future, expansion
of indications is expected for lung, breast, liver, bone, and soft tissue tumors, and we hope to respond
flexibly.
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